Department of Animal Science, Oklahoma Agricultural Experiment Station, Stillwater 74078-0425, USA.
J Anim Sci. 2012 May;90(5):1479-88. doi: 10.2527/jas.2011-4554. Epub 2011 Dec 6.
Three experiments were conducted to evaluate methods of immunization against GnRH on antibody titer, luteal activity, and pregnancy in beef heifers. Experiment 1 evaluated the efficacy of adjuvants with 30 heifers. Control heifers were immunized against human serum albumin (HSA) emulsified in Freund's complete adjuvant (FCA). The other 4 treatments contained GnRH conjugated to HSA (HSA-GnRH) emulsified in FCA, Freund's incomplete adjuvant (FIA), DEAE dextran (DD) + mineral oil (MO), or DD+FIA. Treatment was in the mammary gland for all experiments. Titers against GnRH for heifers immunized against HSA-GnRH with FCA, DD+MO, or DD+FIA were greater than titers for HSA-GnRH with FIA or control heifers (P < 0.01). Body weight was reduced (P < 0.05) in control and FCA heifers compared with FIA, DD+MO, and DD+FIA heifers. Heifers immunized with DD+MO and DD+FIA had fewer granulomas in mammary glands than heifers treated with FCA (P < 0.01). In Exp. 2, 36 heifers were used to determine the effect of the protein conjugated to GnRH on titers against GnRH. Heifers (6/treatment) received a primary immunization against GnRH conjugated to HSA (HSA-GnRH), ovalbumin (OA-GnRH), or keyhole limpet hemocyanin (KL-GnRH), or heifers were immunized against each carrier protein. Antigens were emulsified in DD+FIA. Immunization of heifers against OA-GnRH, KL-GnRH, or HSA-GnRH suppressed luteal activity (P < 0.01) for 23, 16, and 12 wk, respectively, and antibody titers against GnRH were greater (P < 0.01) for 19, 5, and 7 wk, respectively, compared with heifers immunized against the carrier proteins. In Exp. 3, 90 heifers were used to determine the effect of immunization against GnRH on ovarian activity and pregnancy rate. Heifers (30/treatment) received a primary and 2 or 3 booster immunizations against GnRH conjugated to OA, and controls received a primary and 2 booster immunizations against OA. All antigens were emulsified in DD+FIA. At 8 wk after primary immunization, heifers were exposed to fertile bulls for 24 wk. Pregnancy rate was less (P < 0.01) for 3-booster heifers (13%) compared with control (83%) and 2-booster (62%) heifers. We conclude that immunization against GnRH, conjugated to OA and emulsified in DD+FIA, does not influence ADG and produces sufficient titers against GnRH to prevent estrous cycles with few mammary granulomas. Immunization against GnRH with 3 booster immunizations prevented luteal activity and pregnancy in most beef heifers for more than 4 mo.
三项实验旨在评估针对 GnRH 的免疫接种方法对牛小母牛的抗体效价、黄体活动和妊娠的影响。实验 1 评估了佐剂的功效,共有 30 头小母牛参与。对照小母牛接受了与人血清白蛋白 (HSA) 乳化的弗氏完全佐剂 (FCA) 的免疫接种。其他 4 种处理方法包含 GnRH 与 HSA 缀合 (HSA-GnRH),并分别乳化于 FCA、弗氏不完全佐剂 (FIA)、DEAE 葡聚糖 (DD) + 矿物油 (MO) 或 DD+FIA。所有实验均在乳腺中进行治疗。与 FIA 或对照小母牛相比,接受 FCA、DD+MO 或 DD+FIA 免疫接种的 HSA-GnRH 小母牛的 GnRH 抗体效价更高 (P<0.01)。与 FIA、DD+MO 和 DD+FIA 小母牛相比,对照和 FCA 小母牛的体重减轻 (P<0.05)。与接受 FCA 治疗的小母牛相比,接受 DD+MO 和 DD+FIA 治疗的小母牛的乳腺肉芽肿更少 (P<0.01)。在实验 2 中,使用 36 头小母牛来确定与 GnRH 缀合的蛋白质对 GnRH 抗体效价的影响。(6 头/处理)接受 GnRH 与人血清白蛋白 (HSA) 缀合的初次免疫接种 (HSA-GnRH)、卵清蛋白 (OA-GnRH) 或血蓝蛋白 (KL-GnRH),或小母牛接受每种载体蛋白的免疫接种。抗原用 DD+FIA 乳化。与载体蛋白相比,免疫接种 OA-GnRH、KL-GnRH 或 HSA-GnRH 的小母牛的黄体活动分别受到抑制 (P<0.01)23、16 和 12 周,并且对 GnRH 的抗体效价分别提高 (P<0.01)19、5 和 7 周。在实验 3 中,使用 90 头小母牛来确定针对 GnRH 的免疫接种对卵巢活动和妊娠率的影响。(30 头/处理)接受 OA 缀合的 GnRH 的初次和 2 或 3 次加强免疫接种,而对照接受 OA 的初次和 2 次加强免疫接种。所有抗原均用 DD+FIA 乳化。初次免疫接种 8 周后,小母牛与可育公牛接触 24 周。与对照 (83%) 和 2 次加强免疫接种 (62%) 的小母牛相比,3 次加强免疫接种的小母牛的妊娠率较低 (P<0.01)(13%)。我们得出结论,与 OA 缀合并与 DD+FIA 乳化的 GnRH 免疫接种不会影响 ADG,并产生足够的 GnRH 抗体效价,以防止黄体活动和乳腺肉芽肿的发情周期。对 GnRH 进行 3 次加强免疫接种可预防大多数牛小母牛的黄体活动和妊娠,持续时间超过 4 个月。